Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein of 97 kDa (CEP97) is a conserved centriolar protein localized at the distal end of the mother centriole. It acts as a key negative regulator of ciliogenesis by forming a complex with CP110 and capping the centriole, thereby preventing inappropriate cilia formation in cycling cells[4][5]. CEP97 is essential for maintaining centriole structural integrity and proper size; its absence leads to defective centrioles and impaired cilia biogenesis[1][2]. It plays a structural, non-enzymatic role linked to protein complexes involved in centriole stability, and it interacts with the microtubule-modifying enzyme SIRT2. Mutations in CEP97 are associated with rare developmental syndromes such as Seckel syndrome[5]. CEP97 is not currently regarded as a therapeutic target, and there are no known drugs that specifically target it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein of 97 kDa (CEP97).